Phylogeographic analysis of human papillomavirus 58

Science in China, Series C: Life Sciences

Volumn 52, Issue 12, 2009, Pages 1164-1172

  Li, YanYun ^a   Li, ZuoFeng ^b   He, YiFeng ^a   Kang, Yu ^a   Zhang, XiaoYan ^a   Cheng, MingJun ^a   Zhong, Yang ^b,c   Xu, CongJian ^a  

^a OBSTETRICS AND GYNECOLOGY HOSPITAL OF FUDAN UNIVERSITY   (China)

^b Shanghai Bio information Research Center   (China)

^c FUDAN UNIVERSITY   (China)

Author keywords

Cervical cancer; Human papillomavirus 58 (HPV58); Molecular evolution; Phylogeography

Indexed keywords

CAPSID PROTEIN; E6 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 58; HPV L1 PROTEIN, HUMAN PAPILLOMAVIRUS; ONCOPROTEIN; VIRUS DNA;

ALPHAPAPILLOMAVIRUS; ARTICLE; CHEMISTRY; CHINA; CLASSIFICATION; DNA SEQUENCE; FEMALE; GENETICS; GEOGRAPHY; HUMAN; INCIDENCE; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PHYLOGENY; POLYOMAVIRUS INFECTION; UTERINE CERVIX TUMOR; VIROLOGY;

ALPHAPAPILLOMAVIRUS; CAPSID PROTEINS; CHINA; DNA, VIRAL; FEMALE; GEOGRAPHY; HUMANS; INCIDENCE; MOLECULAR SEQUENCE DATA; ONCOGENE PROTEINS, VIRAL; PHYLOGENY; POLYOMAVIRUS INFECTIONS; SEQUENCE ANALYSIS, DNA; UTERINE CERVICAL NEOPLASMS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 58;

EID: 75649086589     PISSN: 10069305     EISSN: 18622798     Source Type: Journal    
DOI: 10.1007/s11427-009-0149-6     Document Type: Article

References (33)

1. Lombard I, Vincent-Salomon A, Validier P, et al. Human papillomavirus genotype as a major determinant of the course of cervical. J Clin Oncol, 1998, 16: 2613-2619.
2. Mclachlin C M. Human papillomavirus in cervical neoplasia: Role, risk factors and implications. Clin Lab Med, 2000, 20: 257-270.
3. Franco E L, Duarte-Franco E, Ferenczy A. Cervical cancer: Epidemiology, prevention and the role of human papillomavirus infection. CMAJ, 2001, 164: 1017-1025.
4. Calleja-Macias I E, Villa L L, Prado J C, et al. Worldwide genomic diversity of the high-risk human papillomavirus types 31, 35, 52, and 58, four close relatives of human papillomavirus type 16. J Virol, 2005, 79: 13630-13640.
5. Clifford G M, Smith J S, Plummer M, et al. Human papillomavirus types in invasive cervical cancer worldwide: A meta-analysis. Br J Cancer, 2003, 88: 63-73.
6. Chan P K, Lam C W, Cheung TH, et al. Association of human papillomavirus type 58 variant with the risk of cervical cancer. J Natl Cancer Inst, 2002, 94: 1249-1301.
7. Lin Q Q, Yu S Z, Qu W, et al. Human papillomavirus types 52 and 58. Int J Cancer, 1998, 75: 484-485.
8. Wu Y, Chen Y, Li L, et al. Associations of high-risk HPV types and viral load with cervical cancer in China. J Clin Virol, 2006, 35: 264-272.
9. Huang S, Afonina I, Miller B A, et al. Human papillomavirus types 52 and 58 are prevalent in cervical cancer from Chinese women. Int J Cancer, 1997, 70: 408-411.
10. Liu J H, Huang X, Liao G W, et al. The comparative study of HPV infection in cervical cancer patients and other risk factors between China and Australia. Chin J Med, 2003, 83: 748-752.
11. Lai H C, Sun C A, Yu M H, et al. Favorable clinical outcome of cervical cancers infected with human papilloma virus type 58 and related types. Int J Cancer, 1999, 84: 553-557.
12. Lai C H, Huang H J, Hsueh S, et al. Human papillomavirus genotype in cervical cancer: A population-based study. Int J Cancer, 2007, 120: 1999-2006.
13. Chan P K, Li W H, Chan M Y, et al. High prevalence of human papillomavirus type 58 in Chinese women with cervical cancer and precancerous lesions. J Med Virol, 1999, 59: 232-238.
14. Wallace R G, Hodac H, Lathrop R H, et al. Lathrop, et al. A statistical phylogeography of influenza A H5N1. Proc Natl Acad Sci USA, 2007, 104: 4473-4478.
15. Stewart A C, Eriksson A M, Manos M M, et al. Intratype variation in 12 human papillomavirus types: A worldwide perspective. J Virol, 1996, 70: 3127-3136.
16. Cerqueira D M, Camara G N, da Cruz M R, et al. Variants of human papillomavirus types 53, 58 and 66 identified in Central Brazil. Virus Genes, 2003, 26: 83-87.
17. Qu W, Jiang G, Cruz Y, et al. PCR detection of human papillomavirus: Comparison between MY09/MY11 and GP5+/GP6+ primer systems. J Clin Microbiol, 1997, 35: 1304-1310.
18. Cheah P L, Looi L M. Biology and pathological associations of the human papillomaviruses: A review. Malays J Pathol, 1998, 20: 1-10.
19. Sichero L, Villa L L. Epidemiological and functional implications of molecular variants of human papillomavirus. Braz J Med Biol Res, 2006, 39: 707-717.
20. Yamada T, Wheeler C M, Halpern A L, et al. Human papillomavirus type 16 variant lineages in United States populations characterized by nucleotide sequence analysis of the E6, L2, and L1 coding segments. J Virol, 1995, 69: 7743-7795.
21. Chen Z, Terai M, Fu L, et al. Diversifying selection in human papillomavirus type 16 lineages based on complete genome analyses. J Virol, 2005, 79: 7014-7036.
22. Ho L, Chan S Y, Burk R D, et al. The genetic drift of human papillomavirus type 16 is a means of reconstructing prehistoric viral spread and the movement of ancient human populations. J Virol, 1993, 67: 6413-6435.
23. Ho L, Chan S Y, Chow V, et al. Sequence variants of human papillomavirus type 16 in clinical samples permit verification and extension of epidemiological studies and construction of a phylogenetic tree. J Clin Microbiol, 1991, 29: 1765-1836.
24. Kirii Y, Iwamoto S, Matsukura T. Human papillomavirus type 58 DNA sequence. Virology, 1991, 185: 424-430.
25. Chan P K, Chang A R, Cheung J L, et al. Determinants of cervical human papillomavirus infection: Differences between high- and low-oncogenic risk types. J Infect Dis, 2002, 185: 28-35.
26. Chan P K, Chang A R, Tam W H, et al. Prevalence and genotype distribution of cervical human papillomavirus infection: Comparison between pregnant women and non-pregnant controls. J Med Virol, 2002, 67: 583-590.
27. Xi L F, Touré P, Critchlow C W, et al. Prevalence of specific types of human papillomavirus and cervical squamous intraepithelial lesions in consecutive, previously unscreened, West-African women over 35 years of age. Int J Cancer, 2003, 103: 803-811.
28. Xin C Y, Matsumoto K, Yoshikawa H, et al. Analysis of E6 variants of human papillomavirus type 33, 52 and 58 in Japanese women with cervical intraepithelial neoplasia/cervical cancer in relation to their oncogenic potential. Cancer Lett, 2001, 170: 19-24.
29. Cho N H, An H J, Jeong J K, et al. Genotyping of 22 human papillomavirus types by DNA chip in Korean women: comparison with cytologic diagnosis. Am J Obstet Gynecol, 2003, 188: 56-62.
30. Bernard H U, Calleja-Macias I E, Dunn S T. Genome variation of human papillomavirus types: Phylogenetic and medical implications. Int J Cancer, 2006, 118: 1071-1076.
31. DeFilippis V R, Ayala F J, Villarreal L P. Evidence of diversifying selection in human papillomavirus type 16 E6 but not E7 oncogenes. J Mol Evol, 2002, 55: 491-499.
32. Villa L L, Costa R L, Petta C A, et al. Prophylactic quadrivalent human papillomavirus (types 6, 11 16 and 18) L1 virus-like particle vaccine in young women a randomized double-blind placebocontrolled multicentre phase II efficacy trial. Lancet Oncol, 2005, 6: 271-278.
33. Harper D M, Franco E L, Wheeler C, et al. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: A randomized controlled trial. Lancet, 2004, 364: 1757-1765.